| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon 97201-3098 [A. B. B., C. W-V. P., R. M. L.], and Division of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, California 94720-3104 [S. M. B.]
The DNA mismatch repair gene hMLH1 is reported to function in mutation avoidance, cell cycle checkpoint control, the cytotoxicity of various DNA -damaging agents, and transcription-coupled nucleotide excision repair. Formal proof of the involvement of hMLH1 in these processes requires single gene complementation. We have stably expressed hMLH1 from a transfected cDNA in Mlh1-deficient mouse embryonic fibroblasts. Expression of hMLH1 restored normal levels of mPMS2 protein, reduced spontaneous base substitution and microsatellite mutations, increased sensitivity to the toxic effects of 6-thioguanine (6-TG), and restored 6-TG-induced cell cycle arrest. Our studies confirm that hMLH1 has an essential role in the maintenance of genomic stability and the potentiation of 6-TG cytotoxicity and provide a system for detailed structure/function analysis of the hMLH1 protein.
This article has been cited by other articles:
![]() |
E. Avdievich, C. Reiss, S. J. Scherer, Y. Zhang, S. M. Maier, B. Jin, H. Hou Jr, A. Rosenwald, H. Riedmiller, R. Kucherlapati, et al. Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis PNAS, March 18, 2008; 105(11): 4247 - 4252. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Candelaria, D Gallardo-Rincon, C Arce, L Cetina, J. Aguilar-Ponce, O Arrieta, A Gonzalez-Fierro, A Chavez-Blanco, E de la Cruz-Hernandez, M. Camargo, et al. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors Ann. Onc., September 1, 2007; 18(9): 1529 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Blasi, I. Ventura, G. Aquilina, P. Degan, L. Bertario, C. Bassi, P. Radice, and M. Bignami A Human Cell-Based Assay to Evaluate the Effects of Alterations in the MLH1 Mismatch Repair Gene. Cancer Res., September 15, 2006; 66(18): 9036 - 9044. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-C. Chen, S. Dudley, W. Hagen, D. Dizon, L. Paxton, D. Reichow, S.-R. Yoon, K. Yang, N. Arnheim, R. M. Liskay, et al. Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse Cancer Res., October 1, 2005; 65(19): 8662 - 8670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Satia, T. Keku, J. A. Galanko, C. Martin, R. T. Doctolero, A. Tajima, R. S. Sandler, and J. M. Carethers Diet, Lifestyle, and Genomic Instability in the North Carolina Colon Cancer Study Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luo, F.-T. Lin, and W.-C. Lin ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage Mol. Cell. Biol., July 15, 2004; 24(14): 6430 - 6444. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lei, Y. Zhu, A. Tomkinson, and L. Sun Measurement of DNA mismatch repair activity in live cells Nucleic Acids Res., July 12, 2004; 32(12): e100 - e100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cortellino, D. Turner, V. Masciullo, F. Schepis, D. Albino, R. Daniel, A. M. Skalka, N. J. Meropol, C. Alberti, L. Larue, et al. From The Cover: The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity PNAS, December 9, 2003; 100(25): 15071 - 15076. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Warnick, B. Dabbas, S. J. Ilstrup, C. D. Ford, and K. A. Strait Cell Type-Dependent Regulation of hMLH1 Promoter Activity Is Influenced by the Presence of Multiple Redundant Elements Mol. Cancer Res., June 1, 2003; 1(8): 610 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tomer, A. B. Buermeyer, M. M. Nguyen, and R. M. Liskay Contribution of Human Mlh1 and Pms2 ATPase Activities to DNA Mismatch Repair J. Biol. Chem., June 7, 2002; 277(24): 21801 - 21809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lan, Z. Sever-Chroneos, M. W. Strobeck, C.-H. Park, R. Baskaran, W. Edelmann, G. Leone, and E. S. Knudsen DNA Damage Invokes Mismatch Repair-dependent Cyclin D1 Attenuation and Retinoblastoma Signaling Pathways to Inhibit CDK2 J. Biol. Chem., March 1, 2002; 277(10): 8372 - 8381. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marra, S. D'Atri, H. Yan, C. Perrera, E. Cannavo', B. Vogelstein, and J. Jiricny Phenotypic Analysis of hMSH2 Mutations in Mouse Cells Carrying Human Chromosomes Cancer Res., November 1, 2001; 61(21): 7719 - 7721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jacob, M. Aguado, D. Fallik, and F. Praz The Role of the DNA Mismatch Repair System in the Cytotoxicity of the Topoisomerase Inhibitors Camptothecin and Etoposide to Human Colorectal Cancer Cells Cancer Res., September 1, 2001; 61(17): 6555 - 6562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pepponi, G. Graziani, S. Falcinelli, P. Vernole, L. Levati, P. M. Lacal, E. Pagani, E. Bonmassar, J. Jiricny, and S. D'Atri hMSH3 overexpression and cellular response to cytotoxic anticancer agents Carcinogenesis, August 1, 2001; 22(8): 1131 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meyers, M. W. Wagner, H.-S. Hwang, T. J. Kinsella, and D. A. Boothman Role of the hMLH1 DNA Mismatch Repair Protein in Fluoropyrimidine-mediated Cell Death and Cell Cycle Responses Cancer Res., July 1, 2001; 61(13): 5193 - 5201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Shcherbakova, M. C. Hall, M. S. Lewis, S. E. Bennett, K. J. Martin, P. R. Bushel, C. A. Afshari, and T. A. Kunkel Inactivation of DNA Mismatch Repair by Increased Expression of Yeast MLH1 Mol. Cell. Biol., February 1, 2001; 21(3): 940 - 951. [Abstract] [Full Text] |
||||
![]() |
R. A. Hardman, C. A. Afshari, and J. C. Barrett Involvement of Mammalian MLH1 in the Apoptotic Response to Peroxide-induced Oxidative Stress Cancer Res., February 1, 2001; 61(4): 1392 - 1397. [Abstract] [Full Text] |
||||
![]() |
J. A. Plumb, G. Strathdee, J. Sludden, S. B. Kaye, and R. Brown Reversal of Drug Resistance in Human Tumor Xenografts by 2'-Deoxy-5-azacytidine-induced Demethylation of the hMLH1 Gene Promoter Cancer Res., November 1, 2000; 60(21): 6039 - 6044. [Abstract] [Full Text] |
||||
![]() |
W. K. Leung, J. J. Kim, L. Wu, J. L. Sepulveda, and A. R. Sepulveda Identification of a Second MutL DNA Mismatch Repair Complex (hPMS1 and hMLH1) in Human Epithelial Cells J. Biol. Chem., May 19, 2000; 275(21): 15728 - 15732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |